Drug Alert: 41 Drug samples including Cipla's TOFAJAK tablets fail To Qualify CDSCO Test

Written By :  Susmita Roy
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2025-01-04 12:30 GMT   |   Update On 2025-01-04 12:30 GMT

New Delhi: In its latest drug alert, the apex drug regulatory body, the Central Drug Standard Control Organization (CDSCO), has flagged 41 medicine batches for failing to qualify for a random drug sample test for November– 2024.

These include Calcium And Vitamin D3 Tablets IP manufactured by Bengal Chemicals and Pharmaceuticals, Paracetamol Tablets IP 500mg manufactured by Karnataka Antibiotics and Pharmaceuticals, Pantoprazole Tablets IP (Opipan-40) manufactured by Orison Pharma International, Telmisartan Tablets IP 40 mg manufactured by Life Max Cancer Laboratories and others.

Furthermore, the list includes popular medicines Tofacitinib Tablets IP 5 mg (TOFAJAK TABLETS) manufactured by Cipla, Itraconazole Capsules BP 200 mg (Itrotus-200) manufactured by Synokem Pharmaceuticals, and IsosorbideMononitrate Sustained Release Tablets 30 mg (Monit30-SR) manufactured by Intas Pharmaceuticals.

The alert further mentioned that as part of the continuous regulatory surveillance, drug samples are picked from sales/distribution point, analyzed and list of Not of Standard Quality (NSQ) drugs are displayed on CDSCO portal on monthly basis. The purpose of displaying the NSQ list is to make stakeholders aware about the NSQ batches identified in the market.

Not of Standard Quality (NSQ) drugs are the drugs that fail to meet the quality standards or specifications are known as Not of Standard Quality (NSQ) drugs. (Further, the term ‘standards of quality’ is defined under the Section 16 (1) (a) of Drugs & Cosmetics Act, 1940, that the ‘standards of quality’ mean that the drug complies with the standards set out in the Second Schedule of the said Act.)

A few of the reasons why the drug samples tested failed were the failure of the assay, failure of the dissolution test, failure of disintegration test, clarity of solution and particulate matter, failure of pH, particulate matter, and description.

The samples collected were tested in five laboratories: RDTL Chandigarh, CDL Kolkata, CDTL Mumbai,CDTL Indore and RDTL-Guwahati.

NOT OF STANDARD QUALITY (NSQ) ALERT FOR THE MONTH OF NOVEMBER – 2024

A. CDSCO/Central Laboratories

S.No

Product/Drug Name

Batch No.

Manufacturing Date

Expiry Date

Manufactured By

NSQ Result

Reported by CDSCO

Laboratory

1.

Glimepride, Pioglitazone Hydrochloride & Metformin Hydrochloride (Extended Release) Tablets (OZOMET-PG 2

)

BE32456

05/2024

04/2026

M/s. Ozone Pharmaceuticals, Village: Katha, Baddi, Distt. Solan (H.P.) 173 205

Assay of Pioglitazone

Central Drugs Laboratory, Kolkata

2.

Sucralfate USP

SCF/24/004 9

05/2024

04/2029

M/s. Par Drugs & Chemicals Limited, 333/1, 333/2, 334,

335, 336/A&B, 337,

338, GIDC Ind.

Estate Phase-2,

Chitra, Bhavnagar- 364004, Gujarat

Spurious Identification & Assay

Central Drugs Laboratory, Kolkata

3.

Sucralfate USP

LSU240401 5

04/2024

03/2029

M/s. Legend Industries (Unit-II), C1/200, 201/4,

Phase-II, GIDC, Opp. Encore Ltd., Naroda, Ahmedabad 382 330,

Spurious Identification & Assay

Central Drugs Laboratory, Kolkata

Gujarat

4.

Compound Sodium Lactate Injection I.P. (Ringers Lactate I.P. ) (RL 500ml)

03BF2443

03/2024

02/2027

M/s. PaschimBanga Pharmaceuticals, NH- 31, Tin Mile Hat, Sonapur Hat, PS- Chopra, Dist-Uttar Dinajpur - 733214 (WB)

Sterility

Central Drugs Laboratory, Kolkata

5.

Promethazine Injection IP 25 mg / ml

4A04070

08/2024

07/2026

M/s. Ciron Drugs & Pharmaceuticals Pvt. Ltd., N-118, 119, 113, 119/1, 119/2 & 118/1,

MIDC, Tarapur, Boisar, Dist-Palghar- 401506 Maharashtra

Assay

Central Drugs Laboratory, Kolkata

6.

Heparin Sodium Injection IP 25000 IU / 5 ml

GV3H001

08/2023

07/2026

M/s. Scott-Edil Pharmacia Ltd., 56, EPIP, Phase-I, Jharmajri, Baddi, Distt. Solan 173205

H.P. (India)

pH, Particulate Matter, Description

Central Drugs Laboratory, Kolkata

7.

Heparin Sodium Injection IP 25000 IU / 5 ml

GV3E001

05/2023

04/2026

M/s. Scott-Edil Pharmacia Ltd., 56, EPIP, Phase-I, Jharmajri, Baddi, Distt. Solan 173205

H.P. (India)

pH, Particulate Matter, Assay of Heparin (Anti- factor Iia activity), Description

Central Drugs Laboratory, Kolkata

8.

Glimepiride Tablets IP 2 mg

GTF5005

09/2023

08/2025

M/s.

SaiMirraInnopharmPv t,Ltd., No-288 & 289,

SIDCO Estate, Ambattur, Chennai- 600 098

Dissolution of Glimepiride

Central Drugs Laboratory, Kolkata

9.

Aspirin Gastro- resistant Tablets IP 75 mg

ANET1107

07/2023

12/2024

M/s. Unicure India Ltd., C-21, 22 & 23

Sector-3, Noida- 201301, Distt.

Test for Salicylic Acid

Central Drugs Laboratory, Kolkata

GautamBudh Nagar (U.P.)

10.

Calcium And Vitamin D3 Tablets IP

BCV-X01

04/2024

09/2025

M/s. Bengal Chemicals & Pharmaceuticals Ltd., At 115 C, Industrial Estate, Pologround, Indore 452 015.

Uniformity of Content of Vitamin D3

Central Drugs Laboratory, Kolkata

11.

Paracetamol Tablets IP 500mg

2555322

12/2022

11/2025

M/s. Karnataka Antibiotics and Pharmaceuticals Ltd., Plot No. 14, II Phase, Peenya, Bengaluru

560 058

Description

Central Drugs Laboratory, Kolkata

12.

Clarithromycin Tablets IP 500 mg

TCRM-010

11/2023

10/2025

M/s. Medipol Pharmaceutical India Pvt. Ltd., 1199/3, Bhud, BaddiDistt.

Solan, H.P., India.

Dissolution

Central Drugs Laboratory, Kolkata

13.

Methylcobalami n Injection (Rejoice)

SLA593

12/2023

05/2025

M/s. Amster Labs, Unit-II, Hilltop, Ind.

Estate, Vill.

BhatauliKalan, Baddi, Distt. Solan, H.P

pH, Particulate Matter, Assay & Description

Central Drugs Laboratory, Kolkata

14.

Enteric Coated Rabeprazole Sodium &Domperidone Sustained Release Capsules (R

LONG-D)

23101006A

10/2023

09/2025

M/s. Resonant Pharmaceuticals Pvt. Ltd., Survey No. 430- 1-A, Nr. Saffro Mellow Color Factory, Village: Navagam 387540, Dist-Kheda,

Gujarat, India.

Dissolution and Assay of Rabeprazole Sodium

Central Drugs Laboratory, Kolkata

15.

Carbimazole Tablets IP 10 mg

TC-3270005

02/2024

01/2026

M/s. Centurion Remedies Pvt. Ltd., G/5, 6 B.I.D.C,

Gorwa, Vadoddara- 390016

Thiamazole& other Related Substances

Central Drugs Laboratory, Kolkata

16.

Clopidogrel Tablets IP (Clopirel-75)

T-2401753

01/2024

12/2025

M/s. Oscar Remedies Pvt. Ltd., Oscar House, BadiMajra,

Yamuna Nagar - 135 001 (HR)

Dissolution

Central Drugs Laboratory, Kolkata

17.

Clobazam Tablets IP 5 mg (ZAMBA 5)

16672

07/2023

07/2026

M/s. ELIKEM

Pharmaceuticals Pvt.

Ltd., 816/1,

Rakanpur, Ta-Kalol, Dist. Gandhinagar,

Gujrat 382721

Uniformity of Content & Dissolution of Clobazam

Central Drugs Laboratory, Kolkata

18.

Pantoprazole Tablets IP (Opipan-40)

23D-T812A

07/2023

06/2025

M/s. Orison Pharma International, Vill. Khari, MauzaOgli, Kala Amb, Distt.

Sirmour - 173030 (H.P.)

Description

RDTL, Guwahati

19.

Ciprofloxacin Tablets U.S.P.

500 mg

T-2401066

01/2024

12/2025

M/s. Rivpra Formulation Pvt. Ltd.., Plot No.8,

Sector-6A, I. I.E. SIDCUL, Haridwar- 249 403 (U.K.).

INDIA.

"Dissolution" of Ciprofloxacin

RDTL, Guwahati

20.

RABEPRAZOL E TABLETS IP

MT-24B25

02/2024

07/2025

M/s.MARTIN& BROWN BIOSCIENCES PVT. LTD., K.No. 918/419,

Malkumajra, Nalagarh Road,

Baddi, Dist. Solan (H.P.)-173205

Assay of Rabeprazole Sodium

RDTL, Guwahati

21.

RABEPRAZOL E TABLETS IP

MT-24B21

02/2024

07/2025

M/s.MARTIN& BROWN BIOSCIENCES PVT. LTD., K.No. 918/419,

Malkumajra,

Assay of Rabeprazole Sodium

RDTL, Guwahati

Nalagarh Road, Baddi, Dist. Solan (H.P.)-173205

22.

Itraconazole Capsules BP 200 mg (Itrotus-

200)

24S2GCA2

82

04/2024

03/2026

M/s. Synokem Pharmaceuticals Ltd., Plot No.56-57, Sector 6A, I.I.E (SIDCUL),

Ranipur (BHEL), Haridwar-249 403 (Uttarakhand)

Dissolution

RDTL, Guwahati

23.

Itraconazole Capsules BP 200 mg (Itradila

200)

IG23038

05/2023

04/2025

M/s. InnovaCaptab Limited, 1281/1, Hilltop Industrial Estate, Near EPIP, Phase-I, Jharmajri, Baddi, Dist. Solan (H.P.) India

Dissolution

RDTL, Guwahati

24.

Itraconazole Capsules B.P. 200 mg (It-Bert

200)

WC819C

11/2023

10/2025

M/s. Saphnix Life Sciences, Village- Barotiwala, Paonta Sahib, Distt. Sirmour,

Himachal Pradesh- 173025

Dissolution

RDTL, Guwahati

25.

Zinc Sulphate Tablets IP 20

mg (Tonzee 20)

ZS-2314

11/2023

10/2025

M/s. Torino Laboratories Pvt. Ltd.,, R.O. 210,

Adamji Building, 413, NarsiNatha Street, Masjid Bunder,

MUMBAI- 400 009.

Disintegration

RDTL, Guwahati

26.

INFUSION SET

50FC670

03/2024

02/2027

M/s.Omex Medical Technology, At Kotadi, Plot No.1, Shivalik Industrial Park, Mehsana Highway, Ta Vijapur, Gujarat, India

Sterility

RDTL, Guwahati

27.

Itraconazole Capsules BP 200 mg (Itropi-

200)

23K-C354

02/2024

01/2026

M/s. Orison Pharma International, Vill. Khari, MauzaOgli, Kala Amb, Distt.

Sirmour - 173030 (H.P.)

Dissolution

RDTL, Guwahati

28.

RABEPRAZOL E TABLETS IP

MT-24B30

02/2024

07/2025

M/s.MARTIN& BROWN BIOSCIENCES PVT. LTD., K.No. 918/419,

Malkumajra, Nalagarh Road, Baddi, Dist. Solan (H.P.)-173205

Assay /Content of Rabeprazole Sodium

RDTL, Guwahati

29.

Primaqine Phosphate Tablets IP 2.5 mg (PQUIN- 2.5)

CN2301

04/2023

09/2025

M/s.CENTURY DRUGS PVT. LTD.,

Plot No. 38, Sector - 3, Pithampur, Dist.

Dhar Madhya Pradesh

Description

RDTL, Guwahati

30.

Telmisartan Tablets IP 40 mg

LMT240520

05/2024

04/2026

M/s.Life Max Cancer Laboratories, Plot No.

106 & 106 A,

Sector6A, IIE, SIDCUL,

Haridwar249403 (U.K)

Description

RDTL, Guwahati

31.

Telmisartan Tablets I.P. 40 mg

LMT240611

05/2024

04/2026

M/s.Life Max Cancer Laboratories, Plot No.

106 & 106 A,

Sector6A, IIE, SIDCUL,

Haridwar249403 (U.K)

Description

RDTL, Guwahati

32.

Esomeprazole MagnesisumTri hydrate (EC)

CPC-0072

08/2023

07/2025

M/s.CycusPharma, Vill. Harraipur, Baddi, Nalagarh Road, Distt.

Dissolution and Assay of Levosulpiride

RDTL, Guwahati

&Levosulpiride (SR) Capsules (ESODENSE-L

Capsules)

Solan (H.P.) - 173 205.

33.

Pantoprazole Gastro- Resistant Tablets IP 40 mg (Pantojack- 40)

T-1261

04/2024

03/2026

M/s.Jackson Laboratories Pvt.Ltd, 22-24, Majitha Road, Bye Pass, Amritsar- 143 001(India)

Dissolution & Description

RDTL, Guwahati

34.

Promethazine Hydrochloride Injection I.P. (PHENERGAN)

2ml

AHH0230

08/2022

07/2025

M/s. NitinLifesciences Ltd, Rampur Ghat Road, Paonta Sahib, Dist. Sirmour173 025 (H.P.)

pH and Assay/ Content of Promethazine Hydrochloride

RDTL, Guwahati

35.

Folic Acid Tablets IP 5 mg (FOLITAS)

T-2406004

06/2024

05/2026

M/s. Aagya Biotech Pvt. Ltd., 1.5 km, Manglour Saharanpur Road, Manglour- 247656, Roorkee,

Distt. Haridwar (U.K), India

"Hydrolysis products (N-(4- aminobenzoyl)- L-Glutamic acid)"

CDTL-Mumbai

36.

Pantoprazole Tablets IP 40

mg (Mb2pan 40 Tablets)

SD6686A

08/2023

07/2025

M/s. Sigma Softgel& Formulation, Plot No.

171, HPSIDC,

Industrial Area, Baddi-1732025, Distt-

Solan (H.P.)

Dissolution (Buffer Stage)

RDTL, Chandigarh

37.

Paracetamol Tablets IP (Paracent 650 Tablets)

24GT079

03/2024

02/2027

M/s.Accent Pharmaceuticals & Diagnostics, Village Bhalon (Seri), Forest

Road, Solan-173212 (H.P.)

Dissolution

RDTL, Chandigarh

38.

Albendazole and Ivermectin Oral

L-24022

06/2024

05/2026

M/s.H.L.HealthcarePv t.Ltd., Plot No.25, Ind.Area, Phase-II,

pH and Assay of Albendazole and Ivermectin

RDTL, Chandigarh

Suspension (Bot Suspension)

Gagret-177201 (H.P.)

39.

IsosorbideMono nitrate Sustained Release Tablets 30 mg (Monit- 30-SR)

K2302484

12/2023

11/2026

M/s. INTAS PHARMACEUTICAL

S LTD., Bagheykhola, Majhitar, Sikkim- 737136, INDIA

Description

RDTL, Chandigarh

40.

Tofacitinib Tablets IP 5 mg (TOFAJAK TABLETS)

4F30009

05/2024

04/2026

M/s.CIPLA LTD,

NO.45, Mangalam Main Rd., Villianur Commune,

Puducherry 605110 INDIA

Identification and Assay of Tofacitinib citrate calculated as

Tofacitinib

RDTL, Chandigarh

41.

Budesonide Nebuliser Suspension BP

- 0.5 mg

(Budecide™ 0.5 mg Nebuliser Solution)

K1090259

02/2024

01/2026

M/s. KamlaAmrut Pharmaceutical LLP, Survey No.: 53,56,57, Nr. KamlaAmrut Industrial Park, Indrad, Ta.: Kadi, Dist.: Mehsana, Gujarat - 382715,

India

Related substances

CDTL Indore

To view the official notice, click the link below:

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News